Fellow of the Academy of Social Sciences, United Kingdom
The scientist’s investigation covers issues in Psychiatry, Mental health, Randomized controlled trial, Public health and Gerontology. The concepts of his Psychiatry study are interwoven with issues in Indirect costs and Dementia. Martin Knapp interconnects Psychological intervention, Social environment, Health care and Quality of life in the investigation of issues within Mental health.
His Randomized controlled trial study combines topics in areas such as Odds ratio, Quality-adjusted life year, Physical therapy and Clinical trial. Martin Knapp has researched Public health in several fields, including Quality of life, Service, Economic cost and Environmental health. Martin Knapp has included themes like Social Welfare and MEDLINE in his Gerontology study.
His scientific interests lie mostly in Psychiatry, Mental health, Gerontology, Nursing and Health care. His research integrates issues of Randomized controlled trial, Clinical psychology and Economic evaluation in his study of Psychiatry. His research investigates the connection between Mental health and topics such as Public health that intersect with issues in Social environment.
The study incorporates disciplines such as Dementia and Quality of life in addition to Gerontology. His work focuses on many connections between Dementia and other disciplines, such as Physical therapy, that overlap with his field of interest in Quality of life. His work on Nursing is being expanded to include thematically relevant topics such as Older people.
Dementia, Gerontology, Psychiatry, Mental health and Psychological intervention are his primary areas of study. His study in Dementia is interdisciplinary in nature, drawing from both Nursing, Quality of life, Randomized controlled trial, Cognition and Quality of life. Martin Knapp usually deals with Gerontology and limits it to topics linked to Economic impact analysis and Government.
Psychiatry is closely attributed to Occupational safety and health in his work. The various areas that Martin Knapp examines in his Mental health study include Loneliness, Peer support and Economic evaluation. His work deals with themes such as Intervention and Systematic review, MEDLINE, which intersect with Psychological intervention.
Martin Knapp spends much of his time researching Dementia, Psychiatry, Mental health, Psychological intervention and Randomized controlled trial. His Dementia research is multidisciplinary, incorporating perspectives in Gerontology, Quality of life, Intervention, Quality of life and Cognition. Martin Knapp works mostly in the field of Psychiatry, limiting it down to concerns involving Economic evaluation and, occasionally, Health economics.
His biological study spans a wide range of topics, including Global health, Public health, Social work and Social isolation. His studies deal with areas such as Qualitative research, Public economics and MEDLINE as well as Psychological intervention. The various areas that Martin Knapp examines in his Randomized controlled trial study include Adverse effect, Physical therapy and Acceptance and commitment therapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cost of disorders of the brain in Europe 2010
Anders Gustavsson;Mikael Svensson;Frank Jacobi;Christer Allgulander.
European Neuropsychopharmacology (2011)
Resources for mental health: scarcity, inequity, and inefficiency
Shekhar Saxena;Graham Thornicroft;Martin Knapp;Harvey Whiteford.
The Lancet (2007)
Financial cost of social exclusion: follow up study of antisocial children into adulthood.
Stephen Scott;Martin Knapp;Juliet Henderson;Barbara Maughan.
BMJ (2001)
Costing psychiatric interventions.
Jennifer Beecham;Martin R J. Knapp.
(1992)
Costs of Autism Spectrum Disorders in the United Kingdom and the United States
Ariane V. S. Buescher;Zuleyha Cidav;Zuleyha Cidav;Martin Knapp;David S. Mandell;David S. Mandell.
JAMA Pediatrics (2014)
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Bengt Winblad;Bengt Winblad;Philippe Amouyel;Sandrine Andrieu;Clive Ballard.
Lancet Neurology (2016)
World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future
Martin James Prince;Adelina Comas-Herrera;Martin Knapp;Maelenn Mari Guerchet.
(2016)
The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial
Tom Burns;Jocelyn Catty;Thomas Becker;Robert E Drake.
The Lancet (2007)
Donepezil and memantine for moderate-to-severe Alzheimer's disease.
Robert Howard;Rupert McShane;James Lindesay;Craig Ritchie.
(2012)
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
David S. Baldwin;Ian M. Anderson;David J. Nutt;Borwin Bandelow.
Journal of Psychopharmacology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Kent
London School of Economics and Political Science
University of Greenwich
University of Nottingham
University of Kent
University of Manchester
King's College London
Lancaster University
University of Sydney
University College London
Simon Fraser University
Columbia University
University of Nottingham
Shibaura Institute of Technology
Jilin University
Harvard University
Radboud University Nijmegen
University of Canterbury
University of Copenhagen
Purdue University West Lafayette
Leiden University Medical Center
Johns Hopkins University
The University of Texas MD Anderson Cancer Center
Vrije Universiteit Amsterdam
University of Bradford
Université Paris Cité